| Product Code: ETC7645310 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Atopic Dermatitis Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Atopic Dermatitis Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Atopic Dermatitis Market - Industry Life Cycle |
3.4 Israel Atopic Dermatitis Market - Porter's Five Forces |
3.5 Israel Atopic Dermatitis Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Atopic Dermatitis Market Revenues & Volume Share, By Mode Of Administration, 2021 & 2031F |
3.7 Israel Atopic Dermatitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Atopic Dermatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of atopic dermatitis in Israel |
4.2.2 Growing awareness about the condition and available treatment options |
4.2.3 Rising focus on research and development for innovative therapies in the market |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of atopic dermatitis treatments |
4.3.2 High cost associated with advanced treatment options |
4.3.3 Limited access to specialized healthcare services in certain regions of Israel |
5 Israel Atopic Dermatitis Market Trends |
6 Israel Atopic Dermatitis Market, By Types |
6.1 Israel Atopic Dermatitis Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Atopic Dermatitis Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Atopic Dermatitis Market Revenues & Volume, By PDE-4 Inhibitor, 2021- 2031F |
6.1.4 Israel Atopic Dermatitis Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.5 Israel Atopic Dermatitis Market Revenues & Volume, By Others, 2021- 2031F |
6.1.6 Israel Atopic Dermatitis Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.7 Israel Atopic Dermatitis Market Revenues & Volume, By Calcineurin Inhibitors, 2021- 2031F |
6.1.8 Israel Atopic Dermatitis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.9 Israel Atopic Dermatitis Market Revenues & Volume, By Pimecrolimus, 2021- 2031F |
6.1.10 Israel Atopic Dermatitis Market Revenues & Volume, By Pimecrolimus, 2021- 2031F |
6.2 Israel Atopic Dermatitis Market, By Mode Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Atopic Dermatitis Market Revenues & Volume, By Topical, 2021- 2031F |
6.2.3 Israel Atopic Dermatitis Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Israel Atopic Dermatitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Israel Atopic Dermatitis Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Atopic Dermatitis Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Atopic Dermatitis Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Atopic Dermatitis Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Atopic Dermatitis Market Import-Export Trade Statistics |
7.1 Israel Atopic Dermatitis Market Export to Major Countries |
7.2 Israel Atopic Dermatitis Market Imports from Major Countries |
8 Israel Atopic Dermatitis Market Key Performance Indicators |
8.1 Number of new atopic dermatitis cases diagnosed annually |
8.2 Adoption rate of novel therapies in the market |
8.3 Patient satisfaction and reported quality of life improvements post-treatment |
9 Israel Atopic Dermatitis Market - Opportunity Assessment |
9.1 Israel Atopic Dermatitis Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Atopic Dermatitis Market Opportunity Assessment, By Mode Of Administration, 2021 & 2031F |
9.3 Israel Atopic Dermatitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Atopic Dermatitis Market - Competitive Landscape |
10.1 Israel Atopic Dermatitis Market Revenue Share, By Companies, 2024 |
10.2 Israel Atopic Dermatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here